Home/Filings/4/0001209191-17-027348
4//SEC Filing

ARATANA THERAPEUTICS, INC. 4

Accession 0001209191-17-027348

CIK 0001509190operating

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 6:06 PM ET

Size

10.6 KB

Accession

0001209191-17-027348

Insider Transaction Report

Form 4
Period: 2017-04-17
St Peter Steven
DirectorPRESIDENT AND CEO
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-04-1746,666113,334 total
    Exercise: $3.14Exp: 2026-01-21Common Stock (46,666 underlying)
  • Exercise/Conversion

    Common Stock

    2017-04-17$3.14/sh+46,666$146,531629,359 total
  • Sale

    Common Stock

    2017-04-17$5.54/sh50,000$277,150582,693 total
Holdings
  • Common Stock

    (indirect: By LLC)
    86,997
Footnotes (4)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2016.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.47 to $5.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]Held in the name of Vie Venture LLC, a Delaware limited liability company ("Vie Venture"). The Reporting Person has sole voting and dispositive power over the shares held by Vie Venture, but disclaims beneficial ownership of the shares held thereby except to the extent of his pecuniary interest therein.
  • [F4]Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on January 29, 2017 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on January 29, 2020, subject to continued service with the Issuer through the applicable vesting dates.

Issuer

ARATANA THERAPEUTICS, INC.

CIK 0001509190

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001509190

Filing Metadata

Form type
4
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 6:06 PM ET
Size
10.6 KB